Search research articles
Contact Us
Filters
Showing results (1-10 of 79) with videos related to
Page
of 8
Sort By:
Pharmaceutical Research
|
November 1, 1995
Does fluid flow across the intestinal mucosa affect quantitative oral drug absorption? Is it time for a reevaluation?
H Lennernäs
Journal of Pharmaceutical Sciences
|
April 21, 1998
Human intestinal permeability
H Lennernäs
The Journal of Pharmacy and Pharmacology
|
July 1, 1997
Human jejunal effective permeability and its correlation with preclinical drug absorption models
H Lennernäs
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
October 31, 2007
Intestinal permeability and its relevance for absorption and elimination
H Lennernäs
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 27, 1999
Repeated oral rifampicin decreases the jejunal permeability of R/S-verapamil in rats
R Sandström, H Lennernäs
Clinical Pharmacokinetics
|
May 1, 1997
Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences
H Lennernäs, G Fager
Pharmaceutical Research
|
January 1, 1993
Regional gastrointestinal absorption of the beta-blocker pafenolol in the rat and intestinal transit rate determined by movement of 14C-polyethylene glycol (PEG) 4000
H Lennernäs, C G Regårdh
Pharmaceutical Research
|
May 1, 1993
Dose-dependent intestinal absorption and significant intestinal excretion (exsorption) of the beta-blocker pafenolol in the rat
H Lennernäs, C G Regårdh
Pharmaceutical Research
|
June 1, 1993
Evidence for an interaction between the beta-blocker pafenolol and bile salts in the intestinal lumen of the rat leading to dose-dependent oral absorption and double peaks in the plasma concentration-time profile
H Lennernäs, C G Regårdh
Pharmaceutical Research
|
September 1, 1996
Comparison between permeability coefficients in rat and human jejunum
U Fagerholm, M Johansson, H Lennernäs
Page
of 8
Search research articles
Search
Showing results (1-10 of 79) with videos related to
Sort By:
Page
of 8
Pharmaceutical Research
|
November 1, 1995
Does fluid flow across the intestinal mucosa affect quantitative oral drug absorption? Is it time for a reevaluation?
H Lennernäs
Journal of Pharmaceutical Sciences
|
April 21, 1998
Human intestinal permeability
H Lennernäs
The Journal of Pharmacy and Pharmacology
|
July 1, 1997
Human jejunal effective permeability and its correlation with preclinical drug absorption models
H Lennernäs
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
October 31, 2007
Intestinal permeability and its relevance for absorption and elimination
H Lennernäs
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 27, 1999
Repeated oral rifampicin decreases the jejunal permeability of R/S-verapamil in rats
R Sandström, H Lennernäs
Clinical Pharmacokinetics
|
May 1, 1997
Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences
H Lennernäs, G Fager
Pharmaceutical Research
|
January 1, 1993
Regional gastrointestinal absorption of the beta-blocker pafenolol in the rat and intestinal transit rate determined by movement of 14C-polyethylene glycol (PEG) 4000
H Lennernäs, C G Regårdh
Pharmaceutical Research
|
May 1, 1993
Dose-dependent intestinal absorption and significant intestinal excretion (exsorption) of the beta-blocker pafenolol in the rat
H Lennernäs, C G Regårdh
Pharmaceutical Research
|
June 1, 1993
Evidence for an interaction between the beta-blocker pafenolol and bile salts in the intestinal lumen of the rat leading to dose-dependent oral absorption and double peaks in the plasma concentration-time profile
H Lennernäs, C G Regårdh
Pharmaceutical Research
|
September 1, 1996
Comparison between permeability coefficients in rat and human jejunum
U Fagerholm, M Johansson, H Lennernäs
Page
of 8